The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
BTMD · Healthcare · Wide moat
On the watchlist
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | WAT | VRTX | BTMD | OPXS |
|---|---|---|---|---|
| Moat Score (0–100) | 80 | 81 (highest) | 80 | 80 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 60 | 95 (highest) | 69 | 95 (highest) |
| Pricing power | 98 | 100 (highest) | — | 21 |
| Returns on capital | 97 | 96 | 100 (highest) | 82 |
| Balance-sheet safety | 74 | 73 | 73 | 100 (highest) |
| Capital allocation | 71 | 39 | 80 | 100 (highest) |
| 238% above value if growth stopped today | 243% above value if growth stopped today | No price data | 176% above value if growth stopped today (largest discount to value if growth stopped today) | |
| Market cap | $26.0B | $126.6B | Not reported | $69.5M |
| Moat tier | Wide moat | Wide moat | Wide moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |